FDA updates guidance on evaluating out-of-specification results for drugs
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchAudit/inspectionComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy